Individualization of diabetes care is a hallmark of its management. As the complexity of patients with diabetes increases and with the constant new stream of published evidence, endocrinologists and diabetologists can further adapt therapy based on the need of the patients seen in clinical practice. In this webinar, international diabetes experts will review the key evidence on four topics in clinical practice. This will include the impact of obesity, stroke, and frailty on diabetes management. Experts will discuss whether metformin should still be considered the first-line treatment option while other therapies may have more significant cardiorenal benefits.\n<\/p>\n
This program has received an unrestricted educational grant or in-kind support from Novo Nordisk A\/S. <\/p>","protected":false},"featured_media":444235,"comment_status":"open","ping_status":"closed","template":"","eb_course_cat":[],"class_list":["post-5503","eb_course","type-eb_course","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\n